Repligen RGEN

Health care sectorNasdaq

Company

Exchange: Nasdaq
Sector: Health care
Industry: Biological Products, (No Diagnostic Substances)
Headquarters: Waltham, Massachusetts
Fiscal year end: 12/31
Next earnings: 10/14, estimated

No member of Congress reported a trade in Repligen RGEN in the past 90 days. Insiders filed 0 purchases and 2 sales on the open market over the same period, a net sale of $2.5M.

Korean holdings rank: Outside the top 50; Korea Securities Depository · released 09/22
Congress trades: No record; Last 90 days · 0 buys · 0 sales
Insider net buying: −$2.5M; Last 90 days · bought $0 · sold $2.5M
Next earnings: 10/14; Estimated from the last four quarters

26-week trading

Common questions

Did Repligen RGEN insiders buy or sell in the past 90 days?: In the past 90 days insiders filed 0 purchases and 2 sales on the open market. Sales came to $2.5M.